You have no items in your shopping cart.
Dr. Derin Keskin joins Immunitrack as our first international scientific advisor. Derin brings with him a strong scientific interest and expertise in computational biology, mass spectrometry-based detection of viral and tumour epitopes, and in determining effective anti-tumor T cell responses for vaccine development.
Derin possesses a deep knowledge of MHC molecules and their involvement within immune-oncology as well as strong experience in the development of better MHC/epitope predictors. Derin and his team have also developed technologies to isolate and sequence single tumor-infiltrating T cells to clone T-cell receptor alpha-beta pairs and determine their epitope specificity. He’s currently the Lead Immunologist at the Translational Immuno-Genomics Laboratory, Dana-Farber Cancer Institute in Boston, MA.
The expertise and knowledge he will bring to Immunitrack is vital to advance our ongoing research into mapping T cell epitopes with therapeutical potential, as well as our work in advancing a best-in-class MHC/epitope prediction algorithm trained on Immunitrack proprietary NeoScreen data. Immunitrack’s CEO Dr. Stephan Thorgrimsen proudly states, “By appointing Dr. Derin Keskin as our first international Scientific advisor, we will strengthen our international outreach, and collaboration with top academic research groups. This will also enable us to better translate our MHC expertise into clinical applications.”
Derin has 80 publications in reputed journals and has made significant contributions to science, with some of his notable ones being an epitope prediction software, HLAthena, that was developed by Derin and his colleagues. His technology and knowledge are also being used to develop neoantigen-based cancer vaccines at the Dana-Farber Cancer Institute. On his new role at Immunitrack, Derin says, “Looking forward to working with Immunitrack to develop better epitope prediction tools” Immunitrack extends a warm welcome to Derin and looks forward to his further contributions as our scientific advisor.
